<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">therapeutic</journal-id><journal-title-group><journal-title xml:lang="ru">Южно-Российский журнал терапевтической практики</journal-title><trans-title-group xml:lang="en"><trans-title>South Russian Journal of Therapeutic Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2712-8156</issn><publisher><publisher-name>РостГМУ</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2712-8156-2024-5-3-54-61</article-id><article-id custom-type="elpub" pub-id-type="custom">therapeutic-530</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Анализ результатов оптической когерентной томографии для оценки эффективности и безопасности имплантируемых биорезорбируемых стентирующих каркасов в отдаленном периоде</article-title><trans-title-group xml:lang="en"><trans-title>Analysis of the results of optical coherence tomography to assess the effectiveness and safety of implantable bioresorbable stenting frames in the long term</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0737-7455</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малеванный</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Malevannyy</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Малеванный Михаил Владимирович, к.м.н., заведующий отделением рентгенэндоваскулярных методов диагностики и лечения № 2</p><p>Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Mikhail V. Malevannyy, Cand. Sci. (Med.), Chief of Department №2 </p><p>Rostov-on-Don </p></bio><email xlink:type="simple">doctorm.m@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6765-2837</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хрипун</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Hripun</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Хрипун Алексей Валерьевич, к.м.н., заместитель главного врача по медицинской части, директор Головного сосудистого центра</p><p>Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Aleksei V. Khripun, Cand. Sci. (Med.), Deputy Chief Physician, Director of the Head Vascular Center</p><p>Rostov-on-Don </p></bio><email xlink:type="simple">khripoun@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0448-9486</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Строков</surname><given-names>Д. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Strokov</surname><given-names>D. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Строков Дмитрий Сергеевич, специалист по рентгенохирургическим диагностике и лечению</p><p>Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Dmitrii S. Strokov, Endovascular Surgeon of Interventional Cardioligy and Radiology</p><p>Rostov-on-Don </p></bio><email xlink:type="simple">diss.240893@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3591-174X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Тадиева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Tadieva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Тадиева Елена Валерьевна, специалист по рентгенохирургическим диагностике и лечению</p><p>Ростов-на-Дону </p></bio><bio xml:lang="en"><p>Elena V. Tadieva, Endovascular Surgeon of Interventional Cardioligy and Radiology</p><p>Rostov-on-Don </p></bio><email xlink:type="simple">ltadieva@ya.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Региональный сосудистый центр ГБУ РО «Ростовская областная клиническая больница»<country>Россия</country></aff><aff xml:lang="en">Regional Vascular Center of the Rostov Regional Clinical Hospital<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>09</month><year>2024</year></pub-date><volume>5</volume><issue>3</issue><fpage>54</fpage><lpage>61</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Малеванный М.В., Хрипун А.В., Строков Д.С., Тадиева Е.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Малеванный М.В., Хрипун А.В., Строков Д.С., Тадиева Е.В.</copyright-holder><copyright-holder xml:lang="en">Malevannyy M.V., Hripun A.V., Strokov D.S., Tadieva E.V.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.therapeutic-j.ru/jour/article/view/530">https://www.therapeutic-j.ru/jour/article/view/530</self-uri><abstract><p>Цель: оценить эффективность и безопасность имплантации эверолимус-покрытых биодеградируемых сосудистых каркасов (БСК) по результатам оптической когерентной томографии (ОКТ) у пациентов с ИБС, которым ранее выполнено чрескожное коронарное вмешательство (ЧКВ). Материалы и методы: изучены данные ОКТ 23 пациентов с ишемической болезнью сердца (ИБС) через 10 лет и более после вмешательства с имплантацией БСК. В качестве оценки эффективности БСК использовались стандартные критерии, основанные на анализе ОКТ. Стентированный сегмент, проксимальная зона до стента и дистальная зона после стента являлись областью интереса. Результаты: исследования показали, что в отдалённом периоде строение артерии в области установленных биодеградируемых каркасов представляет собой совокупность фрагментов атеросклеротической бляшки, резорбированного каркаса и неоинтимы. При визуализации с использованием когерентной томографии, эта структура выглядит как монослой с высокой интенсивностью сигнала. У 42,3% пациентов визуализированы структуры, похожие на фрагменты стентирующего каркаса, но меньшие по размерам, с разобщённой структурой, без чётких контуров и отсутствием типичной формы. В 15,4% случаев было отмечено выраженное положительное ремоделирование коронарной артерии в зоне установки биорезорбируемого каркаса. Выводы: анализ данных когерентной томографии показал, что использование биодеградируемых каркасов эффективно и безопасно, процесс деградации каркасов протекает с увеличением диаметра в стентированной зоне и образованием защитного монослоя, с сохранением проходимости всех боковых ветвей в зоне имплантации.</p></abstract><trans-abstract xml:lang="en"><p>Objective: to evaluate the effectiveness and safety of implantation of everolimus-coated bioabsorbable vascular scaffolds (BSCs) based on the results of optical coherence tomography (OCT) in patients with coronary artery disease who have previously undergone percutaneous coronary intervention (PCI). Materials and methods: OCT data from 23 patients with coronary artery disease (CAD) were studied 10 years or more after intervention with BVS implantation. Standard criteria based on OCT analysis were used to evaluate the efficacy of BVS. The stented segment, proximal zone before the stent, and distal zone after the stent were the areas of interest. Results: in the long-term period, the structure of the artery in the area of the installed biodegradable scaffolds is a combination of fragments of an atherosclerotic plaque, a resorbed scaffold, and neointima. When visualized using coherence tomography, this structure appears as a monolayer with high signal intensity. In 42.3% of patients, structures similar to fragments of the stenting frame were visualized, but smaller in size, with a disconnected structure, without clear contours and the absence of a typical shape. In 15.4% of cases, pronounced positive remodeling of the coronary artery in the area of the installation of the bioresorbable frame was noted. Conclusions: analysis of coherence tomography data showed that the use of biodegradable frames is effective and safe, the process of degradation of the frames occurs with an increase in diameter in the stented zone and the formation of a protective monolayer, while maintaining the patency of all side branches in the implantation zone.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>чрескожное коронарное вмешательство</kwd><kwd>биорезорбируемые стентирующие каркасы</kwd><kwd>биодеградируемые каркасы</kwd><kwd>оптическая когерентная томография</kwd><kwd>отдаленные результаты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>percutaneous coronary intervention</kwd><kwd>bioresorbable stenting scaffolds</kwd><kwd>biodegradable scaffolds</kwd><kwd>optical coherence tomography</kwd><kwd>long-term results</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Jia S, Liu Y, Yuan J. Evidence in Guidelines for Treatment of Coronary Artery Disease. Adv Exp Med Biol. 2020;1177:37-73. DOI: 10.1007/978-981-15-2517-9_2</mixed-citation><mixed-citation xml:lang="en">Jia S, Liu Y, Yuan J. Evidence in Guidelines for Treatment of Coronary Artery Disease. Adv Exp Med Biol. 2020;1177:37-73. DOI: 10.1007/978-981-15-2517-9_2</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Nathan A, Kobayashi T, Kolansky DM, Wilensky RL, Giri J. Bioresorbable Scaffolds for Coronary Artery Disease. Curr Cardiol Rep. 2017;19(1):5. DOI: 10.1007/s11886-017-0812-7</mixed-citation><mixed-citation xml:lang="en">Nathan A, Kobayashi T, Kolansky DM, Wilensky RL, Giri J. Bioresorbable Scaffolds for Coronary Artery Disease. Curr Cardiol Rep. 2017;19(1):5. DOI: 10.1007/s11886-017-0812-7</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Iannaccone M, D’Ascenzo F, Templin C, Omedè P, Montefusco A, Guagliumi G, et al. Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2017;18(2):159-166. DOI: 10.1093/ehjci/jew070</mixed-citation><mixed-citation xml:lang="en">Iannaccone M, D’Ascenzo F, Templin C, Omedè P, Montefusco A, Guagliumi G, et al. Optical coherence tomography evaluation of intermediate-term healing of different stent types: systemic review and meta-analysis. Eur Heart J Cardiovasc Imaging. 2017;18(2):159-166. DOI: 10.1093/ehjci/jew070</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Cassese S, Byrne RA, Jüni P, Wykrzykowska JJ, Puricel S, Ndrepepa G, et al. Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention. 2018;13(13):1565-1573. DOI: 10.4244/EIJ-D-17-00492</mixed-citation><mixed-citation xml:lang="en">Cassese S, Byrne RA, Jüni P, Wykrzykowska JJ, Puricel S, Ndrepepa G, et al. Midterm clinical outcomes with everolimus-eluting bioresorbable scaffolds versus everolimus-eluting metallic stents for percutaneous coronary interventions: a meta-analysis of randomised trials. EuroIntervention. 2018;13(13):1565-1573. DOI: 10.4244/EIJ-D-17-00492</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mahmoud AN, Barakat AF, Elgendy AY, Schneibel E, Mentias A, Abuzaid A, et al. Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials. Circ Cardiovasc Interv. 2017;10(5):e005286. DOI: 10.1161/CIRCINTERVENTIONS.117.005286</mixed-citation><mixed-citation xml:lang="en">Mahmoud AN, Barakat AF, Elgendy AY, Schneibel E, Mentias A, Abuzaid A, et al. Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents: A Meta-Analysis of Randomized Trials. Circ Cardiovasc Interv. 2017;10(5):e005286. DOI: 10.1161/CIRCINTERVENTIONS.117.005286</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ, et al. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet. 2017;390(10096):760-772. DOI: 10.1016/S0140-6736(17)31470-8</mixed-citation><mixed-citation xml:lang="en">Ali ZA, Serruys PW, Kimura T, Gao R, Ellis SG, Kereiakes DJ, et al. 2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials with an individual patient data substudy. Lancet. 2017;390(10096):760-772. DOI: 10.1016/S0140-6736(17)31470-8</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang XL, Zhu L, Wei ZH, Zhu QQ, Qiao JZ, Dai Q, et al. Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;164(11):752-763. DOI: 10.7326/M16-0006</mixed-citation><mixed-citation xml:lang="en">Zhang XL, Zhu L, Wei ZH, Zhu QQ, Qiao JZ, Dai Q, et al. Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;164(11):752-763. DOI: 10.7326/M16-0006</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Коробка В.Л., Хрипун А.В., Малеванный М.В., Куликовских Я.В. Ближайшие и среднеотдаленные результаты чрескожного коронарного вмешательства с имплантацией биорезорбируемых стентирующих каркасов при остром инфаркте миокарда с подъемом сегмента ST. Эндоваскулярная хирургия. 2015;2(1-2):58-68. eLIBRARY ID: 27640351 EDN: XGWEYF</mixed-citation><mixed-citation xml:lang="en">Korobka V.L., Khripun A.V., Malevannyy M.V., Kulikovskikh Ya.V. The short-term and mid-term outcomes of percutaneous coronary intervention with implantation of bioresorbable vascular scaffolds for stemi treatment. Russian journal of endovascular surgery. 2015;2(1-2):58-68. eLIBRARY ID: 27640351 EDN: XGWEYF</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Gori T, Munzel T. First evidence of complete resorption 4 years after bioresorbable scaffold implantation in the setting of ST- segment elevation myocardial infarction. J Am Coll Cardiol Intv. 2017;10(2):200–202.</mixed-citation><mixed-citation xml:lang="en">Gori T, Munzel T. First evidence of complete resorption 4 years after bioresorbable scaffold implantation in the setting of ST- segment elevation myocardial infarction. J Am Coll Cardiol Intv. 2017;10(2):200–202.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Karanasos A, Simsek C, Gnanadesigan M, van Ditzhuijzen NS, Freire R, Dijkstra J, et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J Am Coll Cardiol. 2014;64(22):2343-2356. DOI: 10.1016/j.jacc.2014.09.029</mixed-citation><mixed-citation xml:lang="en">Karanasos A, Simsek C, Gnanadesigan M, van Ditzhuijzen NS, Freire R, Dijkstra J, et al. OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold. J Am Coll Cardiol. 2014;64(22):2343-2356. DOI: 10.1016/j.jacc.2014.09.029</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang XL, Zhu L, Wei ZH, Zhu QQ, Qiao JZ, Dai Q, et al. Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;164(11):752-763. DOI: 10.7326/M16-0006</mixed-citation><mixed-citation xml:lang="en">Zhang XL, Zhu L, Wei ZH, Zhu QQ, Qiao JZ, Dai Q, et al. Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents: A Systematic Review and Meta-analysis. Ann Intern Med. 2016;164(11):752-763. DOI: 10.7326/M16-0006</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">García-García HM, Muramatsu T, Nakatani S, Lee IS, Holm NR, Thuesen L, et al. Serial optical frequency domain imaging in STEMI patients: the follow-up report of TROFI study. Eur Heart J Cardiovasc Imaging. 2014;15(9):987-995. DOI: 10.1093/ehjci/jeu042</mixed-citation><mixed-citation xml:lang="en">García-García HM, Muramatsu T, Nakatani S, Lee IS, Holm NR, Thuesen L, et al. Serial optical frequency domain imaging in STEMI patients: the follow-up report of TROFI study. Eur Heart J Cardiovasc Imaging. 2014;15(9):987-995. DOI: 10.1093/ehjci/jeu042</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Kochman J, Kołtowski Ł, Tomaniak M, Jąkała J, Proniewska K, Legutko J, et al. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold. EuroIntervention. 2018;13(18):e2201-e2209. DOI: 10.4244/EIJ-D-17-00311</mixed-citation><mixed-citation xml:lang="en">Kochman J, Kołtowski Ł, Tomaniak M, Jąkała J, Proniewska K, Legutko J, et al. First serial optical coherence tomography assessment at baseline, 12 and 24 months in STEMI patients treated with the second-generation Absorb bioresorbable vascular scaffold. EuroIntervention. 2018;13(18):e2201-e2209. DOI: 10.4244/EIJ-D-17-00311</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Strandberg E, Zeltinger J, Schulz DG, Kaluza GL. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a fouryear intravascular ultrasound study in normal porcine coronary arteries. Circ Cardiovasc Interv. 2012;5(1):39-46. DOI: 10.1161/CIRCINTERVENTIONS.111.964270</mixed-citation><mixed-citation xml:lang="en">Strandberg E, Zeltinger J, Schulz DG, Kaluza GL. Late positive remodeling and late lumen gain contribute to vascular restoration by a non-drug eluting bioresorbable scaffold: a fouryear intravascular ultrasound study in normal porcine coronary arteries. Circ Cardiovasc Interv. 2012;5(1):39-46. DOI: 10.1161/CIRCINTERVENTIONS.111.964270</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention. 2014;9(11):1271-1284. DOI: 10.4244/EIJV9I11A217</mixed-citation><mixed-citation xml:lang="en">Serruys PW, Onuma Y, Garcia-Garcia HM, Muramatsu T, van Geuns RJ, de Bruyne B, et al. Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months. EuroIntervention. 2014;9(11):1271-1284. DOI: 10.4244/EIJV9I11A217</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
